FLT3 and acute myeloid leukemia: Allogeneic hematopoietic stem cell transplantation is recommended during the first remission period for FLT3-ITD-positive AML, but the high rate of relapse after transplantation is a problem compared with cases with FLT3-ITD-negative AML [60].